Bioprinting Laboratories Inc. focuses on generating multicellular mini-tissues (“organoids”) via “microarray 3D bioprinting” and rapidly screening compounds by multiplexed cell-based assays. We aim at commercializing pillar/perfusion plates and bioprinted organoids on the plates and generating predictive toxicity/efficacy data to serve global in vitro cell-based testing markets.